In the global race for a coronavirus vaccine, the German government is investing €300 million and acquiring a stake in the biotech company CureVac, regarded as one of the leaders in the development of a vaccine in Germany. EURACTIV Germany reports.
The need for fast, accurate and balanced information is always important. We value EURACTIV's good, independent journalism and support this initiative
Mella Frewen, Director General of FoodDrinkEurope
EURACTIV plays a vital role in bringing Europe closer to its citizens. EURACTIV has long recognised that the story of Europe has to be told across the continent, and not just in Brussels. We need to support a truly European and informed debate.